2023年3月9日木曜日
Moderna Set to Invest $1 Billion in China, Yicai ReportsUS, China look to mend ties after bilateral tensions escalated
Moderna CEO may attend signing ceremony Wednesday: report
ByBloomberg News
July 4, 2023 at 9:41 PM GMT+9Updated onJuly 5, 2023 at 2:07 PM GMT+9
Moderna Inc. is set to announce its first investment in China as early as Wednesday as heightened geopolitical tensions puts the spotlight on the Asian nation’s efforts to rebuild ties with foreign firms.
The Cambridge, Massachusetts-based company that developed a messenger RNA vaccine for Covid-19 may reveal multiple projects in China with a total investment size of around $1 billion, local media outlet Yicai reported Tuesday, citing sources it didn’t identify. The drugmaker is also actively seeking communication with Chinese regulators, it said, without providing more detail.
Chief Executive Officer Stéphane Bancel is in Shanghai and will attend the investment signing ceremony, according to the report. Bancel said during a visit in April that the company will speed up investment in the city and is looking to work with Chinese partners to develop new technologies and products, Yicai reported.
A representative for Moderna didn’t respond to Bloomberg News requests for comment on the report.
The potential investment from the vaccine powerhouse comes just days ahead of a high—profile visit to China by Treasury Secretary Janet Yellen as the US seeks to mend ties and reinstate lines of communication with officials in Beijing.
Tensions between the world’s two biggest economies have escalated over a range of issues from national security to a heavy reliance on Chinese supply chains. That’s seen the US take increasingly aggressive measures, including plans by President Joe Biden’s administration to regulate and potentially cut off US corporate investment in the Asian country in sensitive technologies.
For its part, China has been rolling out the red carpet for global business leaders to try and ease concerns around unpredictable policy making that’s deterred foreign investment. President Xi Jinping this week urged nations to spurn decoupling and the severing of supply chains, in contrast to a government decision on Monday to subject two key metals used in chips to export controls.
China has also struggled to make strides in developing mRNA technology at home. The country barred mRNA Covid vaccines, including those made by Moderna, from the mainland in an effort to spur the creation of shots domestically and only granted emergency-use approval for one earlier this year — months after Beijing scrapped virus curbs and unleashed a record wave of infections.
Moderna started a biotechnology company in China this May with registered capital of $100 million, and said it is exploring market opportunities to bring the mRNA platform to China, according to Yicai.
— With assistance by John Liu and Luz Dinghttps://www.bloomberg.com/news/articles/2023-07-04/moderna-to-announce-1-billion-in-china-investments-yicai-says
2023年6月2日金曜日
ｍRNAワクチンを拒否した抗原原罪人大国たる中国でファイザーさんがPaxlovidで大儲け！
https://tokumei10.blogspot.com/2023/06/rnapaxlovid.html
2023年1月3日火曜日
日本になんぞに真の抗原原罪大国世界一の座は譲らないアルね！
https://tokumei10.blogspot.com/2023/01/blog-post_83.html
2022年9月17日土曜日
成人のほぼ全員が抗原原罪人の中国 モデルナのｍRNA型ワクチン購入による苦肉の生存戦略を模索中か？
https://tokumei10.blogspot.com/2022/09/rna_17.html
2 件のコメント:
コロの大元 登場人物を入れ替えて研究続行ですか で 新しいのは人民が協力するので非常にサンプルが多くて世界に貢献でき 偉大な国と自尊心も大満足ということでWinWinですな すばらしい
案外V字の勢いで
超過死亡総数に貢献する？
コメントを投稿